Behavioral Interventions for Cardiovascular Disease
(BETTER P2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve recruitment of Black and Hispanic individuals for heart disease studies. Researchers are testing various invitation methods, such as messages that emphasize helping others, offer incentives, or highlight the prevalence of the condition. They seek to determine which methods increase participation in clinical trials. Individuals with heart disease who receive treatment at clinics with active medical records may be suitable candidates. As an unphased study, this trial provides a unique opportunity to contribute to research that could enhance recruitment strategies and increase diversity in clinical trials.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that these recruitment strategies are safe for increasing trial enrollment?
Research has shown that using various communication methods and incentives to encourage clinical trial participation is generally safe. No evidence suggests that recruitment methods cause harm.
For example, studies on message framing—such as appealing to altruism or highlighting others' participation—examine their influence on behavior without reporting safety concerns. Similarly, offering small financial rewards or lottery entries has been studied for effectiveness in encouraging participation, with no mention of safety risks.
Since this trial tests recruitment strategies rather than a new medical treatment, it involves no physical risks. The trial is in the "Not Applicable" phase, focusing on strategies rather than drug safety. Therefore, participation in this type of study is considered low-risk.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different behavioral strategies can boost participation in cardiovascular research. Unlike typical treatments that focus on medication or surgery, this trial looks at communication techniques like appealing to altruism, using social proof, or offering incentives to see what encourages more people to join studies. By experimenting with different messaging and contact methods, researchers aim to discover the most effective ways to engage potential participants, which could lead to better representation and more robust data in future cardiovascular studies.
What evidence suggests that this trial's recruitment strategies could be effective for increasing enrollment of Black and Hispanic participants in heart disease clinical trials?
Research shows that different ways of presenting messages can encourage more people to join clinical trials. In this trial, participants will be randomized into different arms to test these strategies. One arm will use the Framing Method, appealing to altruism, which encourages helping others and can increase participation. Another arm will use social proof, highlighting that others like the participant are joining, a method proven effective in marketing studies. Additionally, some arms will offer financial incentives, such as small guaranteed payments or chances to win larger amounts, to motivate participation. The method of contact, such as receiving messages from personal clinics or research teams, will also be tested for its effect on response rates. These strategies have been studied and show promise in increasing participation, especially among under-represented groups, in important health studies.12467
Are You a Good Fit for This Trial?
This trial is for Black and Hispanic individuals with active medical records at the participating site. It aims to improve diversity in cardiovascular disease studies by testing different recruitment strategies.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Recruitment Strategy Testing
Testing different recruitment strategies to increase enrollment of Black and Hispanic individuals in cardiovascular cohort studies
Follow-up
Participants are monitored for enrollment outcomes and trust in medical researchers
What Are the Treatments Tested in This Trial?
Interventions
- Framing Method (Appeal to Altruism)
- Framing Method (Opt-Out)
- Framing Method (Social Proof or Perceived Scarcity)
- Incentive Structure
- Method of Contact
- Source of Contact
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
American Heart Association
Collaborator
Emory University
Collaborator